medicines use and safety webinar
play

MEDICINES USE AND SAFETY WEBINAR Welcome to the MUS Webinar on The - PowerPoint PPT Presentation

MEDICINES USE AND SAFETY WEBINAR Welcome to the MUS Webinar on The Falsified Medicines Directive presented by Denise Farmer, Health and Justice Pharmacy Adviser to NHS England The webinar itself will start at 1pm. Shortly before 1pm


  1. MEDICINES USE AND SAFETY WEBINAR • Welcome to the MUS Webinar on The Falsified Medicines Directive presented by Denise Farmer, Health and Justice Pharmacy Adviser to NHS England • The webinar itself will start at 1pm. Shortly before 1pm the SPS webinar host will be doing sound checks so bear with us if you hear this more than once! • To join the audio call 0203 478 5289 access code 141 024 134 • The webinar will be recorded and both recording and slide set will be available on the SPS website – under Networks (you need to be logged onto the SPS site to access the recording) • If you want to make a comment or ask a question – please use the “chat” function (you need to choose to direct your question to “All Participants” from the drop down box) • The presenters will answer questions at the end of the presentation www.sps.nhs.uk 1

  2. Upcoming MUS Events Webinars : WEDNESDAY 14 th November – Patient Group Directions – Tracy Rogers interviews Jo Jenkins THURSDAY 13 th December – Update on use of anticholinergic burden – Delia Bishara FACE TO FACE EVENTS 27 th November – Older People Pharmacy Network (OPNet) annual meeting – Polypharmacy and the WHO medicines safety challenge: Moving from guidance to practice in the care of older people Medicines Use and Safety Update Sept 2018 - link Contact LNWH-tr.MUS-SpecialistPharmacyServices@nhs.net to join networks and receive mailings www.sps.nhs.uk 2

  3. The Falsified medicines Directive Implementation in H&J Denise Farmer October 10 th 2018 www.england.nhs.uk

  4. Falsified Medicines Directive • EU legislation with UK implementation February 2019 • Aims to prevent introduction of counterfeit medicines into the medicines supply chain • Process tracks manufactured product end to end (from factory to patient or healthcare delivery site) • Affects all sectors of healthcare in “healthcare institutions” and pharmacies • Some exemptions permitted (Article 23) which includes prisons (interpreted as all residential custodial environments) • HJ represented at national implementation board www.england.nhs.uk 4

  5. The Falsified Medicines Directive • FMD applies to ALL prescription only medicines & ; • Organisations supplying these medicines, (Manufacturers & Pharmacy Wholesalers). • Healthcare Institutions/pharmacies supplying medicines to patients (Community Pharmacies, Hospital Pharmacies and Dispensing Doctors). • Exclusions (ref. Article 23) include dentists, opticians, paramedics, prisons , hospices and nursing homes. FMD requires Prescription Only Medicines (POMs) to be verified / decommissioned in the supply chain + a couple of P medicines www.england.nhs.uk

  6. The Delegated Regulation (EU) 2016/161 - Published on 9 February 2016 – implementation, EU wide from 9th February 2019 Anti-tamper device (ATD) Unique identifier (UI) www.england.nhs.uk

  7. How does it work? www.england.nhs.uk

  8. www.england.nhs.uk 8

  9. Key Points for Community/dispensing Pharmacy • (Community) pharmacies are expected to decommission on supply to the patient. • Ideally barcode scan at point of dispensing would generate a decommission message that is ‘held’ until the medicines are collected by the patient: Then scan bag of medicines handed over. • Wholesale items (bulk stock) can be decommissioned on supply for Article 23 recipients – otherwise must be decommissioned on receipt at other healthcare organisation • Can be scanned back into repository within 10 days • Guidance will be provided about what to do if a medicine is scanned and an error message comes up www.england.nhs.uk

  10. Implementation in H&J • Article 23 exemption allows wholesaler to decommission bulk stock delivered to H&J healthcare providers (term “prison” interpreted as all custodial residential settings) • On-site pharmacies in H&J are acting as community pharmacies: Will need to decommission medicines once bagged up and sent to the wing (or handed to the patient if collecting from the pharmacy) • External pharmacies supplying named patient medicines to prisons will decommission the medicines as they are bagged up ready for delivery to HJ site • Rationale: Equivalence and accounts for community pharmacy model www.england.nhs.uk 10

  11. Scenario 1: On-site pharmacy Wholesaler delivery to HJ Pharmacy HJ pharmacy - Not dispenses medicine Detainee collects decommissioned & decommissions it from pharmacy as it is supplied to wings (or patient) Pharmacy with WDL Wholesaler delivery Healthcare provider receives of bulk stock to decommissioned dispensed healthcare provider: medicines and stock e.g. Decommissioned Methadone, vaccines etc . by wholesaler www.england.nhs.uk 11

  12. Scenario 2: Off-site pharmacy e.g. Community pharmacy or other prison pharmacy External Pharmacy Wholesaler delivery dispenses medicine and to pharmacy - Not decommissions it then decommissioned delivers to H&J site Pharmacy with WDL Wholesaler delivery Healthcare provider receives of bulk stock to HJ decommissioned named patient healthcare provider: medicines from pharmacy and Decommissioned decommissioned stock e.g. by wholesaler Methadone, vaccines etc . www.england.nhs.uk 12

  13. Putting it simply……. • The dispensing pharmacy (on or off site) decommissions named patient medicines that are dispensed against prescriptions they receive from H&J • Wholesalers decommission bulk stock before it is delivered to the healthcare provider in H&J (but not to the pharmacy if it is on-site). www.england.nhs.uk 13

  14. This agreement means……. • No need to develop TPP HJIS to scan medicines to decommission them  • No need for H&J provider staff to scan medicines as they receive them OR as they supply them to the patient = Zero impact on medicines queues.  • Only impact for H&J commissioned services is on-site pharmacies (x42- all in prisons)  . • SARCs and Police custody settings exempt as not healthcare institutions  • Provides equivalence for people in H&J to people in primary care  www.england.nhs.uk 14

  15. Decommissioning in HJ pharmacies • 42 on-site pharmacies in H&J in England: Not all registered pharmacies • Pharmacy dispensing system providers should be developing software to enable FMD scanning and comms with the UK repository • Blue tooth scanners and hard-wired scanners will be OK in H&J but not wireless/WiFi • FMD comms under development and NHS Digital working to support IT infrastructure • NHS England H&J will liaise with commissioners and providers where on-site pharmacies are to support implementation • Non-registered HJ pharmacies that are same legal entity as healthcare provider could use hospital model for FMD www.england.nhs.uk 15

  16. What are next steps: Strategic • Clarify/confirm: • Pharmacy PMR system providers for H&J are on track for developing software • Partnership and support from NHS Digital • Scanner choices and fitness for H&J- link with HMPPS • On-site pharmacy leads identified for H&J to link with • Costs of IT infrastructure and training and who pays? • Comms needed for • Commissioners and HJ senior leads in NHS E • external pharmacy providers • Other stakeholders • Outcomes from the consultation on FMD to inform plans • Close working with Wholesalers www.england.nhs.uk 16

  17. Priority actions for on-site H&J pharmacies • Clarify/confirm: • Your Pharmacy PMR system providers are on track for developing software • Ask software providers about • compatible 2D barcode scanner choices • User training • FMD pharmacy lead to be named and advise NHS E H&J which PMR system is being used • Start thinking about dispensing workflow and whether this is impacted/needs to change due to need for scanning POM packs. www.england.nhs.uk 17

  18. Further information • Read the info about FMD- Useful links  Main FMD site: Link  Sign up to the UK FMD newsletter: email FMD.safetyfeatures@mhra.gov.uk and ask to be added to their mailing list  Check out the PSNC FMD web-pages and resources: Link  Check out FMD FAQs (secondary care but it’s relevant and useful for H&J): Link  Fantastic community pharmacy FMD group web pages: https://fmdsource.co.uk/ www.england.nhs.uk 18

  19. Questions? www.sps.nhs.uk 19

  20. Poll Question Number 1 Overall I found the webinar content useful to me: • Agree strongly • Agree • Disagree • Disagree strongly www.sps.nhs.uk 10/10/2018 20

  21. Poll Question Number 2 I would recommend this learning event to others: • Agree strongly • Agree • Disagree • Disagree strongly www.sps.nhs.uk 10/10/2018 21

  22. Upcoming MUS Events Webinars : WEDNESDAY 14 th November – Patient Group Directions – Tracy Rogers interviews Jo Jenkins THURSDAY 13 th December – Update on use of anticholinergic burden – Delia Bishara FACE TO FACE EVENTS 27 th November – Older People Pharmacy Network (OPNet) annual meeting – Polypharmacy and the WHO medicines safety challenge: Moving from guidance to practice in the care of older people Medicines Use and Safety Update Sept 2018 - link Contact LNWH-tr.MUS-SpecialistPharmacyServices@nhs.net to join networks and receive mailings www.sps.nhs.uk 22

Recommend


More recommend